- Home
- Equipment
- asia middle east
- cancer treatment
Show results for
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Cancer Treatment Equipment Supplied In Asia Middle East
49 equipment items found
Manufactured by:TxinnoBioscience Inc. based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. ...
by:Pars Isotope Co based inTehran, IRAN
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to prostate tumor cells, facilitating the destruction of malignant cells. This unique action stems from its characteristic as a gamma emitter, allowing not ...
by:OncoStem Diagnostics Pvt. Ltd. based inBengaluru, INDIA
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast provides information about the risk of recurrence of early-stage, hormone receptor-positive breast cancer patients. ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus®PLUS is a unique proton therapy solution for leading cancer centers striving to meet a large and growing patient base's treatment needs while further advancing your clinical reputation in cancer care. Its cutting-edge features can be configured into a tailored solution to meet your research, clinical, and business objectives. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
These tests detect DNA mutations by analyzing certain genes extracted from the patient's blood and tumor samples based on ddPCR platform which is optimized for companion diagnostics. They select patients who benefit the effectiveness of cancer ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Deargen, together with its partner Optipharm, created an Artificial Intelligence model that predicts epitope and implemented epitope scanning in silico, and is currently conducting research and development such as cancer treatment vaccine and epitope library ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
Lung cancer is a metastatic cancer which the cancer cells are developed in the bronchial tubes or alveoli and grow along the blood vessel or lymphatic vessel. There are two types of lung cancer based on the sizes and shape of the cancer cell; non-small cell lung cancer (NSCLC) takes 75% and small ...
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
Primary aim is in assessing procoagulant states associated with cancer and cancer therapies, to inform physician’s decision making on initiating, pursuing or stopping anticoagulant prophylaxis in cancer patient. ...
Manufactured by:Shengkang Fine Chemical Co., Ltd based inHong Kong, CHINA
Name Erlotinib. Molecular Formula C22H23N3O4. Molecular Weight 393.44. CAS Registry Number 183321-74-6. Application Treatment of pancreatic cancer. ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES028 and the BiME platform are designed for potent activation of phagocytosis and directly kill tumor cells for treatment of solid tumors. We expect to develop ES028 as a monotherapy to provide an “eat-me” signal that can induce full activation of macrophage phagocytosis towards CLDN18.2-expressing tumors, which include gastric cancer and pancreatic ...
Manufactured by:Medgyn Products, Inc. based inAddison, ILLINOIS (USA)
In 2019, WHO issued new guidelines for the use of thermal ablation for cervical pre-cancerous lesions. While they continue to recommend cryotherapy, the WHO has offered thermal ablation as an alternative method of treatment for specific environments. MedGyn is pleased to announce its latest device: MedGyn’s MTA-100 Thermal Ablation System. The device is a ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
AlphaLiquid®100 is a test that enables the detection of biomarkers which can predict the efficacy/resistance of targeted therapy for one blood test across 118 cancer-related genes. During cancer patients’ treatment journey, a simple blood draw can be used to support monitoring the treatment response and change the ...
Manufactured by:Santa Cruz Biotechnology, Inc. based inDallas, TEXAS (USA)
Pheophorbide a is a chlorophyll-related compound studied for its anti-tumor and anti-cancer ...
Manufactured by:EirGenix, Inc based inNew Taipei City, TAIWAN
CRM197 (Cross Reacting Material 197) is a non-toxic mutant of diphtheria toxin (58 Kd). CRM197 has been tested in animals studies and it has been demonstrated to lack toxicity. CRM197 can be used as a carrier protein for vaccine delivery. It acts by helping polysaccharide antigens to bind on and be internalized into antigen-presenting cells. This in turn induces T-cell-dependent responses. ...
by:IBA based inLouvain-La-Neuve, BELGIUM
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into benefits for the patients. The Proteus® design enhances the patient experience by fostering a soothing environment while making the medical ...
Manufactured by:Elpiscience based inShanghai, CHINA
Activation of OX40 enhances T-cell expansion, differentiation, and the generation of memory T-cells. OX40 antibodies have been clinically tested to expand activated T cells and suppress regulatory T cells in the treatment of ...
Manufactured by:Surgnova Healthcare Technologies based inChaoyang District, CHINA
Dophi™ N3000 Electroporation System is designed for tumor ablation with advanced precision, safety and reliability. Powered by Irreversible Electroporation (IRE) technology, Dophi™ N3000 can ablate tumors in complex anatomical environment. “IRE is a promising method for treatment of tumors near blood vessels, nerves, bile ducts, and connective tissues as these structures remains ...
by:B dot Medical Inc. based inEdogawa-ku, JAPAN
We are trying to overturn the image that society has of radiotherapy and proton therapy with our innovative technology. We are developing proton therapy with the hope of making it accessible to all cancer ...
Manufactured by:Cellworks Research India Private Limited based inBangalore, INDIA
The Cellworks Platform biosimulates how a patient’s unique cancer will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. Therapy biosimulation is the ability to predict the phenotype response of a human cell to an external stimulus, such as a drug ligand or radiation. We ...